Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia (AML) After Allogeneic Stem Cell Transplantation
Phase of Trial: Phase I/II
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 14 Sep 2016 Last checked against ClinicalTrials.gov record.
- 29 Aug 2016 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 29 Aug 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.